Price$0.77-0.00 (-0.32%)
03:00 PM05:45 PM
News · 26 weeks580%
2025-12-072026-05-31
Mix3390d
- Other16(48%)
- SEC Filings14(42%)
- Insider2(6%)
- Analyst1(3%)
Latest news
25 items- SECAdagio Medical Holdings Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- PRAdagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular TachycardiaPMA Submission Supported by FULCRUM-VT Pivotal Trial Data — 209 Patients Across 20 Leading Centers; Breakthrough Device Designation Previously Granted Marks the First-Ever PMA Submission for a Purpose-Built VT Ablation System in a $5.8B Market Adagio Medical Holdings, Inc (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the submission of its Premarket Approval ("PMA") application to the U.S. Food and Drug Administration ("FDA") for the vCLAS Ventricular Ablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia ("VT") in patients w
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Adagio Medical Holdings IncSCHEDULE 13G/A - Adagio Medical Holdings, Inc. (0002006986) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Adagio Medical Holdings IncSCHEDULE 13G/A - Adagio Medical Holdings, Inc. (0002006986) (Subject)
- SECSEC Form 10-Q filed by Adagio Medical Holdings Inc10-Q - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- SECAdagio Medical Holdings Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- SECSEC Form DEF 14A filed by Adagio Medical Holdings IncDEF 14A - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- PRAdagio Medical to Participate in the BofA Securities 2026 Health Care ConferenceAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 4:35pm PDT in Las Vegas. Presentation Information A live webcast and replay of the session will be accessible at https://bofa.veracast.com/webcasts/bofa/healthcare2026/051rbr.cfm or on the Company's website at https://investors.adagiomedical.com. About Adagio Medical Holdings, Inc. Adagio is a medical device company focused on developing and commercializing products for the treatment of c
- SECAdagio Medical Holdings Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- PRAdagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System84% Freedom From Shock and 59% Freedom From VT Recurrence in FULCRUM-VT Pivotal IDE Trial Meet Safety and Effectiveness Endpoints and Replicate CryoCure-VT Results First and Only Ablation Technology to Show Equivalent Effectiveness Across Ischemic and Non-Ischemic Cardiomyopathy All From Endocardial Approach Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported six month results from its FULCRUM-VT Investigational Device Exemption ("IDE") clinical trial, which will be used to support the Company's application for Food and Drug Administration ("FDA") Premarket
- SECAdagio Medical Holdings Inc filed SEC Form 8-K: Shareholder Director Nominations8-K - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- ANALYSTPiper Sandler initiated coverage on Adagio Medical Holdings with a new price targetPiper Sandler initiated coverage of Adagio Medical Holdings with a rating of Overweight and set a new price target of $3.00
- SECAdagio Medical Holdings Inc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- PRAdagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation SystemDesigned to Deliver Faster, More Efficient Ablation with Improved Usability on Established, Titratable, Endocardial-Approach ULTA Platform Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to expand the Company's FULCRUM-VT trial to evaluate the safety and effectiveness of the Company's next-generation vCLAS Ultra-Low Temperature Ablation (ULTA) Ventricular Ablation System for the treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT).
- PRAdagio Medical to Participate in the 25th Annual Needham Virtual ConferenceAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be participating at the 25th Annual Needham Virtual Conference being held April 13-16, 2026. About Adagio Medical Holdings, Inc. Adagio is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cardiac (ULTA) ablation technology. ULTA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue, all
- SECSEC Form EFFECT filed by Adagio Medical Holdings IncEFFECT - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- SECSEC Form EFFECT filed by Adagio Medical Holdings IncEFFECT - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- SECSEC Form S-8 POS filed by Adagio Medical Holdings IncS-8 POS - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- SECSEC Form POS AM filed by Adagio Medical Holdings IncPOS AM - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- SECSEC Form POS AM filed by Adagio Medical Holdings IncPOS AM - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- PRAdagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the pivotal results from the FULCRUM-VT study have been accepted for presentation in a late-breaking clinical science session at Heart Rhythm 2026 (HRS), the annual meeting of the Heart Rhythm Society. This is the first Investigational Device Exemption (IDE) study powered to evaluate the safety and effectiveness of Ultra-Low Temperature Ablation ("ULTA", formerly "ULTC") for the treatment of scar-related ventricular tachycardia (VT) in both ischemic and non-ischemic population. "Having FULCRUM-VT data
- SECSEC Form POS AM filed by Adagio Medical Holdings IncPOS AM - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- SECSEC Form POS AM filed by Adagio Medical Holdings IncPOS AM - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- SECSEC Form 424B3 filed by Adagio Medical Holdings Inc424B3 - Adagio Medical Holdings, Inc. (0002006986) (Filer)
- SECSEC Form 424B3 filed by Adagio Medical Holdings Inc424B3 - Adagio Medical Holdings, Inc. (0002006986) (Filer)
ADGM FAQ
5 questionsWhere does ADGM stock trade?
Adagio Medical Holdings Inc (ADGM) is listed on NASDAQ.What sector and industry is ADGM in?
Adagio Medical Holdings Inc operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about ADGM?
Adagio Medical Holdings Inc has had 2 recent analyst actions on file. The most recent action was from Piper Sandler: Overweight with a $300.00 price target on 2026-04-14. Recent price targets range from $300.00 to $400.00.What companies are similar to ADGM?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare ADGM side-by-side with any of them on Quantisnow.How can I track ADGM on Quantisnow?
Quantisnow aggregates Adagio Medical Holdings Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ADGM to receive live email and push alerts on every new disclosure.